Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Moser

Showing results (331-340 of 500) with videos related to

Pageof 50
Sort By:
Biomedizinische Technik. Biomedical Engineering|September 18, 2013
Mechanical Properties of a Photopolymerizable Hydrogel for Intervertebral Disc ReplacementA Schmocker, A Khoushabi, D Pioletti, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2020
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodiesKelsey Baron, Justin C Moser, Shiven Patel, et al.
Toxicology and Applied Pharmacology|October 17, 1998
Gestational exposure to chlorpyrifos: apparent protection of the fetus?T L Lassiter, S Padilla, S R Mortensen, et al.
Journal of Chromatography. A|October 18, 2008
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatographyK S Joseph, Annette C Moser, Sara B G Basiaga, et al.
Deutsche Medizinische Wochenschrift (1946)|November 2, 1991
[Cardiac metastasis as cause of therapy-resistant heart failure]C Moser, N Risse, H J Langer, et al.
Acta Oncologica (Stockholm, Sweden)|January 11, 2020
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanomaJustin C Moser, Guo Wei, Sarah V Colonna, et al.
Regulatory Toxicology and Pharmacology : RTP|May 5, 2005
Analyses of neurobehavioral screening data: benchmark dose estimationYiliang Zhu, Zhihong Jia, Wei Wang, et al.
FEBS Letters|August 26, 1998
Non-inhibiting perturbation of the primary energy conversion site (Qo site) in Rhodobacter capsulatus ubihydroquinone: cytochrome c oxidoreductase (cytochrome bc1 complex)R E Sharp, A Palmitessa, B R Gibney, et al.
Pancreas|August 4, 2021
Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal AdenocarcinomaMargaret Kelsey Baron, Xuechen Wang, Christopher Nevala-Plagemann, et al.
Journal of Dentistry|June 26, 2021
Proximal caries infiltration - Pragmatic RCT with 4 years of follow-upH Meyer-Lueckel, A Wardius, J Krois, et al.
Pageof 50

Showing results (331-340 of 500) with videos related to

Sort By:
Pageof 50
Biomedizinische Technik. Biomedical Engineering|September 18, 2013
Mechanical Properties of a Photopolymerizable Hydrogel for Intervertebral Disc ReplacementA Schmocker, A Khoushabi, D Pioletti, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2020
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodiesKelsey Baron, Justin C Moser, Shiven Patel, et al.
Toxicology and Applied Pharmacology|October 17, 1998
Gestational exposure to chlorpyrifos: apparent protection of the fetus?T L Lassiter, S Padilla, S R Mortensen, et al.
Journal of Chromatography. A|October 18, 2008
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatographyK S Joseph, Annette C Moser, Sara B G Basiaga, et al.
Deutsche Medizinische Wochenschrift (1946)|November 2, 1991
[Cardiac metastasis as cause of therapy-resistant heart failure]C Moser, N Risse, H J Langer, et al.
Acta Oncologica (Stockholm, Sweden)|January 11, 2020
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanomaJustin C Moser, Guo Wei, Sarah V Colonna, et al.
Regulatory Toxicology and Pharmacology : RTP|May 5, 2005
Analyses of neurobehavioral screening data: benchmark dose estimationYiliang Zhu, Zhihong Jia, Wei Wang, et al.
FEBS Letters|August 26, 1998
Non-inhibiting perturbation of the primary energy conversion site (Qo site) in Rhodobacter capsulatus ubihydroquinone: cytochrome c oxidoreductase (cytochrome bc1 complex)R E Sharp, A Palmitessa, B R Gibney, et al.
Pancreas|August 4, 2021
Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal AdenocarcinomaMargaret Kelsey Baron, Xuechen Wang, Christopher Nevala-Plagemann, et al.
Journal of Dentistry|June 26, 2021
Proximal caries infiltration - Pragmatic RCT with 4 years of follow-upH Meyer-Lueckel, A Wardius, J Krois, et al.
Pageof 50